期刊
EXPERT REVIEW OF ANTICANCER THERAPY
卷 10, 期 11, 页码 1675-1677出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/ERA.10.161
关键词
bevacizumab; clinical trials; glioma; MGMT; molecular markers; new agents; temozolomide